BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34541812)

  • 1. Re-evaluation of the prognostic significance of retropharyngeal node metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Chen B; Zhan Z; Pan J; Xiao Y; Tang L; Guo Q; Xu Y; Zong J; Zhang R; Xu H; Lin S
    Asia Pac J Clin Oncol; 2022 Apr; 18(2):e173-e181. PubMed ID: 34541812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value and staging classification of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Tang LL; Guo R; Zhou G; Sun Y; Liu LZ; Lin AH; Mai H; Shao J; Li L; Ma J
    PLoS One; 2014; 9(10):e108375. PubMed ID: 25302611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Mao YP; Tang LL; Chen L; Sun Y; Qi ZY; Zhou GQ; Liu LZ; Li L; Lin AH; Ma J
    Chin J Cancer; 2016 Dec; 35(1):103. PubMed ID: 28031050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy.
    Li WF; Sun Y; Mao YP; Chen L; Chen YY; Chen M; Liu LZ; Lin AH; Li L; Ma J
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):249-56. PubMed ID: 23200171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.
    Sun Y; Tang LL; Chen L; Li WF; Mao YP; Liu LZ; Lin AH; Li L; Ma J
    BMC Cancer; 2012 Feb; 12():68. PubMed ID: 22336097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of small lymph node metastases in patients with nasopharyngeal carcinoma: Clinical implications for prognosis and treatment.
    Xu P; Min Y; Blanchard P; Feng M; Zhang P; Luo Y; Fan Z; Lang J
    Head Neck; 2017 Feb; 39(2):305-310. PubMed ID: 27627795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
    Jiang C; Gao H; Zhang L; Li H; Zhang T; Ma J; Liu B
    BMC Cancer; 2020 Jul; 20(1):667. PubMed ID: 32680466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis and staging of parotid lymph node metastasis in nasopharyngeal carcinoma: An analysis in 10,126 patients.
    Zhang Y; Zhang ZC; Li WF; Liu X; Liu Q; Ma J
    Oral Oncol; 2019 Aug; 95():150-156. PubMed ID: 31345383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value and Staging Classification of Lymph Nodal Necrosis in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.
    Feng Y; Cao C; Hu Q; Chen X
    Cancer Res Treat; 2019 Jul; 51(3):1222-1230. PubMed ID: 30590003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of both cervical lymph nodes and retropharyngeal lymph nodes has prognostic value for N1 patients with nasopharyngeal carcinoma.
    Shi Q; Shen C; Kong L; Wang X; Ding J; Gao Y; Xu T; Hu C
    Radiat Oncol; 2014 Jan; 9():7. PubMed ID: 24393418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The study of clinical long-term effect and prognostic factors in nasopharyngeal carcinoma after intensity modulated radiation therapy].
    Liu K; Han Y; Ma B
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(21):1177-83. PubMed ID: 24616996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Wan Y; Tian L; Zhang G; Xin H; Li H; Dong A; Liang Y; Jing B; Zhou J; Cui C; Chen M; Sun Y; Xie C; Liu L; Shao Y
    Radiother Oncol; 2019 Feb; 131():35-44. PubMed ID: 30773185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical treatment considerations in the intensity-modulated radiotherapy era for parotid lymph node metastasis in patients with nasopharyngeal carcinoma.
    Lin C; Lu N; Liang JL; Guo J; Gu LW; Sun R; Guo L; Yang Q
    Radiother Oncol; 2023 Sep; 186():109802. PubMed ID: 37423477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of it.
    Li WZ; Liu GY; Lin LF; Lv SH; Qiang MY; Lv X; Wu YS; Liang H; Ke LR; Wang DL; Yu YH; Qiu WZ; Liu KY; Guo X; Li JP; Zou YJ; Xiang YQ; Xia WX
    Radiother Oncol; 2020 Apr; 145():101-108. PubMed ID: 31931288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined prognostic value of pretreatment anemia and cervical node necrosis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: A large-scale retrospective study.
    Zhang LL; Zhou GQ; Li YY; Tang LL; Mao YP; Lin AH; Ma J; Qi ZY; Sun Y
    Cancer Med; 2017 Dec; 6(12):2822-2831. PubMed ID: 29034992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of tumor necrosis on treatment sensitivity and long-term survival in nasopharyngeal carcinoma.
    Liang SB; Chen LS; Yang XL; Chen DM; Wang DH; Cui CY; Xie CB; Liu LZ; Xu XY
    Radiother Oncol; 2021 Feb; 155():219-225. PubMed ID: 33217495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal Size Threshold for MRI-Detected Retropharyngeal Lymph Nodes to Predict Outcomes in Nasopharyngeal Carcinoma: A Two-Center Study.
    Zhu Y; Luo C; Zhou S; Li H; Liu L; Kou KI; Lei F; Zhang G; Cao D; Liang Z
    AJR Am J Roentgenol; 2024 Jan; 222(1):e2329984. PubMed ID: 37753859
    [No Abstract]   [Full Text] [Related]  

  • 18. Suggestions for lymph node classification of UICC/AJCC staging system: a retrospective study based on 1197 nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
    Guo Q; Pan J; Zong J; Zheng W; Zhang C; Tang L; Chen B; Cui X; Xiao Y; Chen Y; Lin S
    Medicine (Baltimore); 2015 May; 94(20):e808. PubMed ID: 25997052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of rare periparotid recurrence after parotid gland-sparing intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Xu Y; Zhang M; Yue Q; Zong J; Lin J; Sun R; Qiu S; Lin S; Pan J
    Cancer Radiother; 2016 Jul; 20(5):377-83. PubMed ID: 27372558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.
    Huang CL; Guo R; Li JY; Xu C; Mao YP; Tian L; Lin AH; Sun Y; Ma J; Tang LL
    Eur Radiol; 2020 Feb; 30(2):816-822. PubMed ID: 31650266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.